Asset Details

MbrlCatalogueTitleDetail

Do you wish to reserve the book?

Myelin-oligodendrocyte glycoprotein antibody-associated disease

by Marignier, Romain , Ciccarelli, Olga , Pittock, Sean , Weinshenker, Brian , Alexopoulos, Harry , Amato, Maria-Pia , Brilot, Fabienne , Leite, Maria-Isabel , Selmaj, Krzysztof , Waters, Patrick , Siva, Aksel , Stankoff, Bruno , Paul, Friedemann , Traboulsee, Anthony , Palace, Jacqueline , Asgari, Nasrin , Linington, Christopher , Sato, Douglas Kazutoshi , Kim, Ho Jin , Meinl, Edgar , Petzold, Axel , Chitnis, Tanuja , Tintore, Mar , Banwell, Brenda , Reindl, Markus , Aktas, Orhan , Hacohen, Yael , Capobianco, Marco , Fujihara, Kazuo , Vukusic, Sandra , Pröbstel, Anne-Katrin , Cobo-Calvo, Alvaro , Derfuss, Tobias , Jacob, Anu , Waubant, Emmanuelle , Bennett, Jeffrey , Kleiter, Ingo , Lassmann, Hans , De Sèze, Jérôme , Deiva, Kumaran , Hemmer, Bernhard

in Adolescent / Adult / Adults / Age / Antibodies / Aquaporin 4 / Autoantibodies - blood / Biomarkers / Brain research / Child / Demyelinating Autoimmune Diseases, CNS - diagnosis / Demyelinating Autoimmune Diseases, CNS - immunology / Demyelinating Autoimmune Diseases, CNS - pathology / Demyelinating Autoimmune Diseases, CNS - physiopathology / Demyelination / Disability / Disease / Encephalomyelitis / Genotype & phenotype / Glycoproteins / Humans / Immunologic Factors - pharmacology / Life Sciences / Middle Aged / Multiple sclerosis / Myelin / Myelin-Oligodendrocyte Glycoprotein - immunology / Neuromyelitis / Neurons and Cognition / Oligodendrocyte-myelin glycoprotein / Pathology / Patients / Proteins / Young Adult

2021

Yes Please

Hey, we have placed the reservation for you!

By the way, why not check out events that you can attend while you pick your title.

Oops! Something went wrong.

Looks like we were not able to place the reservation. Kindly try again later.

Are you sure you want to remove the book from the shelf?

Myelin-oligodendrocyte glycoprotein antibody-associated disease

2021

Confirm

Do you wish to request the book?

Myelin-oligodendrocyte glycoprotein antibody-associated disease

2021

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy

How would you like to get it?

Submit

We have requested the book for you!

Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.

Oops! Something went wrong.

Looks like we were not able to place your request. Kindly try again later.

Journal Article

Myelin-oligodendrocyte glycoprotein antibody-associated disease

Marignier, Romain,

Ciccarelli, Olga,

Pittock, Sean,

Weinshenker, Brian,

Alexopoulos, Harry,

Amato, Maria-Pia,

Brilot, Fabienne,

Leite, Maria-Isabel,

Selmaj, Krzysztof,

Waters, Patrick,

Siva, Aksel,

Stankoff, Bruno,

Paul, Friedemann,

Traboulsee, Anthony,

Palace, Jacqueline,

Asgari, Nasrin,

Linington, Christopher,

Sato, Douglas Kazutoshi,

Kim, Ho Jin,

Meinl, Edgar,

Petzold, Axel,

Chitnis, Tanuja,

Tintore, Mar,

Banwell, Brenda,

Reindl, Markus,

Aktas, Orhan,

Hacohen, Yael,

Capobianco, Marco,

Fujihara, Kazuo,

Vukusic, Sandra,

Pröbstel, Anne-Katrin,

Cobo-Calvo, Alvaro,

Derfuss, Tobias,

Jacob, Anu,

Waubant, Emmanuelle,

Bennett, Jeffrey,

Kleiter, Ingo,

Lassmann, Hans,

De Sèze, Jérôme,

Deiva, Kumaran,

Hemmer, Bernhard

2021

Overview

Myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a recently identified autoimmune disorder that presents in both adults and children as CNS demyelination. Although there are clinical phenotypic overlaps between MOGAD, multiple sclerosis, and aquaporin-4 antibody-associated neuromyelitis optica spectrum disorder (NMOSD) cumulative biological, clinical, and pathological evidence discriminates between these conditions. Patients should not be diagnosed with multiple sclerosis or NMOSD if they have anti-MOG antibodies in their serum. However, many questions related to the clinical characterisation of MOGAD and pathogenetic role of MOG antibodies are still unanswered. Furthermore, therapy is mainly based on standard protocols for aquaporin-4 antibody-associated NMOSD and multiple sclerosis, and more evidence is needed regarding how and when to treat patients with MOGAD.

Share this book

Add to My Shelf

Publisher

Elsevier Ltd,Elsevier Limited

Subject

Adolescent

/ Adult

/ Adults

/ Age

/ Antibodies

/ Aquaporin 4

/ Autoantibodies - blood